Integrated Diagnostics Holdings plc (IDHC) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

This webinar is being recorded and summarized. Hello, everyone. This is Ahmed Mottaz from EFG Hermes, and welcome to IDH's first Half of 25 Results Conference Call. I'm pleased to be joined with Dr. Hamid Sherbini, Chief Executive Officer, Sharif Al-Zaini, Chief Financial Officer, and Tahereh Yahya, Director of Investor Relations. As usual, the company will start with a brief presentation, and then we'll open for Q&A. IDH, please go ahead. Good afternoon, ladies and gentlemen, and thank you, Ahmed, and thank you, everyone, for joining us for IDH's second quarter analyst call. My name is Tariq Yahya, and I am IDH Investor Relations Director. Joining me today, we have Dr. Hendry Shrivini, our CEO, Mr. Shrivizini, our CFO. Dr. Hendry will begin the call with a summary of the latest period main highlights. After that, I will discuss in more details the main highlights. microeconomic and geopolitical trends seen across our market. Mr. Sharif will offer a deeper analysis for our financial performance. We will then end the call with Q&A. I will hand over the call to Dr. Hend. Thank you very much, Tor, and good afternoon, everyone. I'm Dr. Hendrish Ferdini, CEO of IDH. At the halfway point of what has so far been a very remarkable year, we are pleased to report another strong set of financial and operational results. Our performance in the first six months of 2025 highlights once more the effectiveness of our growth and investment strategies, which are enabling us to capture growth-based growth across our markets while driving sustained margin improvement. Our results for the period have also been supported by improving operating conditions across our footprint. We are particularly happy to see that our home and largest market of Egypt has remained on an improving trajectory...